Skip to main content

and
  1. Article

    Open Access

    Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study

    There is an increasing interest for real-life data on drug use in many countries. Reimbursement authorities more and more request observational studies to assess the conditions of use of the products but also ...

    Dominique Simon, Bruno Detournay, Evelyne Eschwege, Stephane Bouée in Diabetes Therapy (2014)

  2. No Access

    Article

    PS7 - 2. Glycemic control and all-cause mortality risk in type 1 diabetes patients: the EURODIAB Prospective Complications Study

    Glycemic targets and the benefit of intensive glucose control are currently under debate as intensive glycemic control has been suggested to have negative effects on mortality risk in type 2 diabetes patients....

    Sabita S. Soedamah-Muthu in Nederlands Tijdschrift voor Diabetologie (2013)